At the time of writing, Charles River Laboratories International Inc [CRL] stock is trading at $102.67, down -3.19%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CRL shares have gain 2.93% over the last week, with a monthly amount drifted -37.91%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Charles River Laboratories International Inc [NYSE: CRL] stock has seen the most recent analyst activity on March 21, 2025, when Goldman downgraded its rating to a Neutral and also revised its price target to $170 from $190. Previously, Citigroup upgraded its rating to Neutral on March 04, 2025, and elevated its price target to $175. On March 03, 2025, upgrade upgraded it’s rating to Neutral but maintained its price target of $188 on the stock. William Blair downgraded its rating to a Mkt Perform. UBS downgraded its rating to a Neutral and reduced its price target to $185 on January 17, 2025. CLSA downgraded its rating to Underperform for this stock on November 18, 2024, but kept the price target unchanged to $164. In a note dated November 07, 2024, CLSA upgraded an Hold rating on this stock but restated the target price of $205.
For the past year, the stock price of Charles River Laboratories International Inc fluctuated between $91.86 and $254.15. Currently, Wall Street analysts expect the stock to reach $303.6 within the next 12 months. Charles River Laboratories International Inc [NYSE: CRL] shares were valued at $102.67 at the most recent close of the market. An investor can expect a potential return of 195.7% based on the average CRL price forecast.
Analyzing the CRL fundamentals
According to Charles River Laboratories International Inc [NYSE:CRL], the company’s sales were 4.05B for trailing twelve months, which represents an -1.08% plunge. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 100.35 points at the first support level, and at 98.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 104.45, and for the 2nd resistance point, it is at 106.23.
Ratios To Look Out For
It is important to note that Charles River Laboratories International Inc [NYSE:CRL] has a current ratio of 1.41. In addition, the Quick Ratio stands at 1.13 and the Cash Ratio stands at 0.2. Considering the valuation of this stock, the price to sales ratio is 1.25, the price to book ratio is 1.52 and price to earnings (TTM) ratio is 400.27.
Transactions by insiders
Recent insider trading involved FOSTER JAMES C, Chairman, President and CEO, that happened on Feb 20 ’25 when 6075.0 shares were purchased. Corporate Executive VP & COO, Girshick Birgit completed a deal on Feb 20 ’25 to buy 1514.0 shares. Meanwhile, EVP, Corp Strategy & Develop LaPlume Joseph W sold 4400.0 shares on Feb 20 ’25.
